Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Nerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 9, pp. 1437-1453.e8
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings
Hau Kiu Edna Au, Mark Isalan, Michał Mielcarek
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 192
An overview of current COVID-19 vaccine platforms
Abdou Nagy, Bader Y. Alhatlani
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2508-2517
Open Access | Times Cited: 152
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Germline-encoded amino acid–binding motifs drive immunodominant public antibody responses
Ellen Shrock, Richard T. Timms, Tomasz Kula, et al.
Science (2023) Vol. 380, Iss. 6640
Open Access | Times Cited: 55
Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins
Ning Jia, Dinshaw J. Patel
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 8, pp. 563-579
Closed Access | Times Cited: 78
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy
Dennis Makafui Dogbey, Valeria Esperanza Sandoval Torres, Emmanuel Adebowale Fajemisin, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 11, pp. 2719-2738
Open Access | Times Cited: 28
Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
Kleopatra Rapti, Dirk Grimm
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48
Cryo-electron Microscopy of Adeno-associated Virus
Scott M. Stagg, Craig Yoshioka, Omar Davulcu, et al.
Chemical Reviews (2022) Vol. 122, Iss. 17, pp. 14018-14054
Open Access | Times Cited: 31
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Ruth Hunegnaw, Anna N. Honko, Lingshu Wang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 675
Closed Access | Times Cited: 27
The ice age – A review on formulation of Adeno-associated virus therapeutics
Philip Grossen, Irini Skaripa Koukelli, Joost van Haasteren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 190, pp. 1-23
Open Access | Times Cited: 18
Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model
Karina Krotova, Hisae Kuoch, Colin Caine, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 28, pp. 301-311
Open Access | Times Cited: 16
AAV-based gene delivery of antimicrobial peptides to combat drug-resistant pathogens
Piyush Baindara, Roy Dinata, Chandra S. Boosani, et al.
Applied and Environmental Microbiology (2025)
Open Access
Metalloparticle‐Engineered Pickering Emulsion Displaying AAV‐Vectored Vaccine for Enhancing Antigen Expression and Immunogenicity Against Pathogens
Zhaofei Guo, Fuhua Wu, Chenqi Guo, et al.
Advanced Materials (2025)
Closed Access
A novel platform for engineered AAV-based vaccines
Sabrina Babutzka, Miranda Gehrke, Αναστασία Παπαδοπούλου, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101418-101418
Open Access
Safety and Immunogenicity of Recombinant Adeno‐Associated Virus‐Vectored African Swine Fever Virus Antigens
A. G. Galeeva, М. А. Ефимова, G.S. Frolov, et al.
Veterinary Medicine International (2025) Vol. 2025, Iss. 1
Open Access
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
Romain Marlin, Delphine Desjardins, Vanessa Contreras, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors
Helena Costa Verdera, Carmen Unzu, Erika Valeri, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 836-852
Closed Access | Times Cited: 13
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Wei Zhan, Manish Muhuri, Phillip W.L. Tai, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity
Fuhua Wu, Shuang Luo, Yongshun Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 2219-2233
Open Access | Times Cited: 20
A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors
Kevin Chih‐Yang Huang, Chia-Ying Lai, Wei-Ze Hung, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 1, pp. 123-136
Open Access | Times Cited: 19
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
Gelareh Abdolmaleki, Mina Taheri, Sarina Paridehpour, et al.
DARU Journal of Pharmaceutical Sciences (2022) Vol. 30, Iss. 2, pp. 379-406
Open Access | Times Cited: 18
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
Abdul Aziz Al-Fattah Bin Yahaya, Kanwal Khalid, Hui Xuan Lim, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 624-624
Open Access | Times Cited: 10
Viruses as biomaterials
Tao Yang, Yingfan Chen, Yajing Xu, et al.
Materials Science and Engineering R Reports (2023) Vol. 153, pp. 100715-100715
Closed Access | Times Cited: 10
Targeted DNA Demethylation: Vectors, Effectors and Perspectives
Naohiro Yano, Alexey V. Fedulov
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1334-1334
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top